Page last updated: 2024-08-26

phorbolol myristate acetate and Nasopharyngeal Carcinoma

phorbolol myristate acetate has been researched along with Nasopharyngeal Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, JK; Chu, WK; Dai, PM; Li, HL; Pao, CC1

Other Studies

1 other study(ies) available for phorbolol myristate acetate and Nasopharyngeal Carcinoma

ArticleYear
Nanog expression is negatively regulated by protein kinase C activities in human cancer cell lines.
    Carcinogenesis, 2013, Volume: 34, Issue:7

    Topics: Carcinoma; Cell Proliferation; Disease Progression; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Gene Silencing; Hep G2 Cells; Homeodomain Proteins; Humans; Isoenzymes; Mutagenesis, Site-Directed; Nanog Homeobox Protein; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Octamer Transcription Factor-3; Promoter Regions, Genetic; Protein Kinase C-alpha; Protein Kinase C-delta; RNA, Messenger; SOXB1 Transcription Factors; Tetradecanoylphorbol Acetate; Transcription, Genetic

2013